Advanced search
Publication Cover
Biomarkers in Medicine Volume 3, 2009 - Issue 5
Submit an article Journal homepage
74
Views
1
CrossRef citations to date
0
Altmetric
Theme: Biomarkers: paving the way for better stratification in heart failure - Review

Prognostic Utility of Cardiac Troponin in Heart Failure: a Novel Role For An Established Biomarker

Colette E Jackson1 BHF Cardiovascular Research Centre, University of Glasgow,126 University Place,Glasgow,G12 8TA,UK. Correspondence[email protected]
,
Jonathan R Dalzell1 BHF Cardiovascular Research Centre, University of Glasgow,126 University Place,Glasgow,G12 8TA,UK.
&
Roy S Gardner2 Scottish Advanced Heart Failure Unit,Golden Jubilee National Hospital,Clydebank,Glasgow,G81 4HX,UK
Pages 483-493 | Published online: 08 Oct 2009

Bibliography

  • Dickstein K , Cohen-SolalA, FilippatosGet al. : ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008.Eur. J. Heart Fail.10(10), 933–989 (2008).
  • Takeda S , YamashitaA, MaedaK, MaédaY: Structure of the core domain of human cardiac troponin in the Ca2+ saturated form.Nature424(6944), 35–41 (2003).
  • Babuin L , JaffeAS: Troponin: the biomarker of choice for the detection of cardiac injury.CMAJ173(10), 1191–1202 (2005).
  • Thygesen K , AlpertJS, WhiteHDet al. ; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction: Universal definition of myocardial infarction. Circulation116(22), 2634–2653 (2007).
  • Heeschen C , HammCW, GoldmannB, DeuA, LangenbrinkL, White HD; the Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) study investigators: Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet354(9192), 1757–1762 (1999).
  • Morrow DA , AntmanEM, TanasijevicMet al. : Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.J. Am. Coll. Cardiol.36(6), 1812–1817 (2000).
  • Morrow DA , CannonCP, RifaiNet al. ; TACTICS-TIMI 18 Investigators: Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA286(19), 2405–2412 (2001).
  • Antman EM , TanasijevicMJ, ThompsonBet al. : Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.N. Engl. J. Med.335(18), 1342–1349 (1996).
  • Hamwi SM , SharmaAK, WeissmanNJet al : Troponin-I elevation in patients with increased left ventricular mass. Am. J. Cardiol.92(1), 88–90 (2003) .
  • Lauer B , NiederauC, KühlUet al. : Cardiac troponin T in patients with clinically suspected myocarditis.J. Am. Coll. Cardiol.30(5), 1354–1359 (1997).
  • Brandt RR , FilzmaierK, HanrathP: Circulating cardiac troponin I in acute pericarditis.Am. J. Cardiol.87(11), 1326–1328 (2001) .
  • La Vecchia L , OttaniF, FaveroLet al. : Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism.Heart90(6), 633–637 (2004).
  • Freda BJ , TangWH, Van Lente F, Peacock WF, Francis GS: Cardiac troponins in renal insufficiency: review and clinical implications. J. Am. Coll. Cardiol.40(12), 2065–2071 (2002).
  • ver Elst KM , SpapenHD, NguyenDN, GarbarC, HuyghensLP, GorusFK: Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock.Clin. Chem.46(5), 650–657 (2000).
  • Cardinale D , SandriMT, ColomboAet al. : Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy.Circulation109(22), 2749–2754 (2004).
  • Bleier J , VorderwinklerKP, FalkensammerJet al. : Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damage.Clin. Chem.44(9), 1912–1918 (1998).
  • Antman EM : Decision making with cardiac troponin tests.N. Engl. J. Med.346(26), 2079–2082 (2002).
  • Capasso JM , MalhotraA, LiP, ZhangX, ScheuerJ, AnversaP: Chronic nonocclusive coronary artery constriction impairs ventricular function, myocardial structure, and cardiac contractile protein enzyme activity in rats.Circ. Res.70(1), 148–162 (1992).
  • Clarke MS , CaldwellRW, ChiaoH, MiyakeK, McNeilPL: Contraction-induced cell wounding and release of fibroblast growth factor in heart.Circ. Res.76(6), 927–934 (1995).
  • Kaye D , PimentalD, PrasadSet al. : Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro.J. Clin. Invest.97(2), 281–291 (1996).
  • Page E , Upshaw-EarleyJ, GoingsG: Permeability of rat atrial endocardium, epicardium, and myocardium to large molecules. Stretch-dependent effects.Circ. Res.71(1), 159–173 (1992).
  • Hessel MH , AtsmaDE, van der Valk EJ, Bax WH, Schalij MJ, van der Laarse A: Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch.455(6), 979–986 (2008).
  • Ross RS , BorgTK: Integrins and the myocardium.Circ. Res.88(11), 1112–1119 (2001).
  • Perna ER , MacínSMet al., Cimbaro Canella JP : High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure. Med. Sci. Monit.10(3), CR90–CR95 (2004).
  • Nishio Y , SatoY, TaniguchiRet al. : Cardiac troponin T vs other biochemical markers in patients with congestive heart failure.Circ. J.71(5), 631–635 (2007).
  • Missov E , CalzolariC, PauB: Circulating cardiac troponin I in severe congestive heart failure.Circulation96(9), 2953–2958 (1997).
  • Horwich TB , PatelJ, MacLellanWR, FonarowGC: Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure.Circulation108, 833–838 (2003).
  • Hudson MP , O‘ConnorCM, GattisWAet al. : Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.Am. Heart J.147(3), 546–552 (2004).
  • Latini R , MassonS, AnandISet al. ; Val-HeFT investigators: Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation116(11), 1242–1249 (2007).
  • Yin WH , ChenJW, FengAN, LinSJ, YoungS: Multimarker approach to risk stratification among patients with advanced chronic heart failure.Clin. Cardiol.30, 397–402 (2007).
  • Miller WL , HartmanKA, BurrittMFet al. : Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.Circulation116, 249–257 (2007).
  • Pascual-Figal DA , Manzano-FernandezS, PastorFet al. : Troponin-T monitoring in outpatients with nonischemic heart failure.Rev. Esp. Cardiol.61(7), 678–686 (2008).
  • Sato Y , YamadaT, TaniguchiRet al. : Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes.Circulation103(3), 369–374 (2001).
  • Eagle KA , LimMJ, DabbousOHet al. ; GRACE Investigators: A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA291(22), 2727–2733 (2004).
  • Morrow DA , AntmanEM, CharlesworthAet al. : TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy.Circulation102(17), 2031–2037 (2000).
  • Levy WC , MozaffarianD, LinkerDTet al. : The Seattle Heart Failure Model: prediction of survival in heart failure.Circulation113(11), 1424–1433 (2006).
  • Pocock SJ , WangD, PfefferMAet al. : Predictors of mortality and morbidity in patients with chronic heart failure.Eur. Heart J.27(1), 65–75 (2006).
  • Wedel H , McMurrayJJ, LindbergMet al. ; on behalf of the CORONA study group: Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal proB-type natriuretic peptide. Eur. J. Heart Fail.11(3), 281–291 (2009).
  • Felker GM , LeimbergerJD, CaliffRMet al. : Risk stratification after hospitalization for decompensated heart failure.J. Card. Fail.10(6), 460–466 (2004).
  • Fonarow GC , AdamsKFet al. Jr, Abraham WT ; ADHERE Scientific Advisory Committee, Study Group and Investigators: Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA293(5), 572–580 (2005).
  • Aaronson KD , SchwartzJS, ChenTM, WongKL, GoinJE, ManciniDM: Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.Circulation95(12), 2660–2667 (1997).
  • Lee DS , AustinPC, RouleauJL, LiuPP, NaimarkD, TuJV: Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.JAMA290(19), 2581–2587 (2003).
  • Vazquez R , Bayes-GenisA, CygankiewiczIet al. ; on behalf of MUSIC investigators: The MUSIC risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. Eur. Heart J.30(9), 1088–1096 (2009).
  • Ishii J , NomuraM, NakamuraYet al. : Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.Am. J. Cardiol.89(6), 691–695 (2002).
  • Gheorghiade M , Gattis Stough W, Adams KF Jr, Jaffe AS, Hasselblad V, O‘Connor CM: The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF). Am. J. Cardiol.96(6A), 18G–25G (2005).
  • You JJ , AustinPC, AlterDA, KoDT, TuJV: Relation between cardiac troponin I and mortality in acute decompensated heart failure.Am. Heart J.153(4), 462–470 (2007).
  • Shah MR , HasselbladV, TasissaGet al. : Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).Am. J. Cardiol.100(9), 1427–1433 (2007).
  • Metra M , NodariS, ParrinelloGet al. : The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.Eur. J. Heart Fail.9(8), 776–786 (2007).
  • Sakhuja R , GreenS, OestreicherEMet al. : Amino-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure.Clin. Chem.53(3), 412–420 (2007).
  • Peacock WF et al. 4th, De Marco T, Fonarow GC ; ADHERE investigators: Cardiac troponin and outcome in acute heart failure. N. Engl. J. Med. 358(20), 2117–2126 (2008).
  • Fonarow GC , PeacockWF, HorwichTBet al. ; ADHERE Scientific Advisory Committee and investigators: Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am. J. Cardiol.101(2), 231–237 (2008).
  • Johnson W , OmlandT, HallCet al. : Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.J. Am. Coll. Cardiol.39(10), 1623–1629 (2002).
  • Fitzgerald RL , CremoR, GardettoNet al. : Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.Am. Heart J.150(3), 471–477 (2005).
  • Del Carlo CH , Pereira-BarrettoAC, Cassaro-StrunzC, Latorre Mdo R, Ramires JA: Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure. J. Card. Fail.10(1), 43–48 (2004).
  • Kuwabara Y , SatoY, MiyamotoTet al. : Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes.Circ. J.71(7), 1047–1051 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.